Charles River Laboratories International Inc Insider Trading
Every director, officer and 10% holder of Charles River Laboratories International Inc has to report each trade in its stock within two business days of making it. This is those filings.
CRL on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| Shannon M ParisottoCEVP, Disc & Safety Assessment2026-10-05981 shat $308.44 | Sale10b5-1 plan | $302.6K |
| James C FosterDirector2026-08-2533.6K shat $300.00 | Sale10b5-1 plan | $10.1M |
| Shannon M ParisottoCEVP, Disc & Safety Assessment2026-08-192K shat $294.12 | Sale10b5-1 plan | $599.7K |
| Nancy C AndrewsDirector2026-08-18573 shat $285.24 | Sale | $163.4K |
| Birgit GirshickChief Executive Officer2026-08-116.5K shat $279.90 | Sale10b5-1 plan | $1.8M |
| Shannon M ParisottoCEVP, Disc & Safety Assessment2026-08-113.7K shat $279.66 | Sale10b5-1 plan | $1M |
| James C FosterDirector2026-08-1028.7K shat $275.00 | Sale10b5-1 plan | $7.9M |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-061.3K shat $259.07 | Sale | $330.1K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-06901 shat $260.63 | Sale | $234.8K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-06810 shat $261.45 | Sale | $211.8K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-06213 shat $262.37 | Sale | $55.9K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-06620 shat $263.94 | Sale | $163.6K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-06482 shat $265.17 | Sale | $127.8K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-06404 shat $258.53 | Sale | $104.4K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-061.2K shat $258.53 | Sale | $311.5K |
| Michael Gunnar KnellSVP, Finance and CAO2026-08-06736 shat $258.53 | Sale | $190.3K |
| Victoria L CreamerEVP & Chief People Officer2026-08-064.2K shat $259.16 | Sale | $1.1M |
| Shannon M ParisottoCEVP, Disc & Safety Assessment2026-08-055K shat $263.00 | Sale10b5-1 plan | $1.3M |
| James C FosterDirector2026-06-2975K shat $225.00 | Sale10b5-1 plan | $16.9M |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on CRL
Follow Charles River Laboratories International Inc (CRL) by email
New trades in Charles River Laboratories International Inc (CRL) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.